Zhejiang Batai Medical Technology

About Zhejiang Batai Medical Technology

Zhejiang Batai Medical Technology Co., Ltd. (Barty Medical), established in August 2015, is a high-tech enterprise specializing in the development, manufacturing, and sales of medical devices for vascular intervention. Based in Hangzhou, China, the company operates from a facility that includes a 1,900 to 5,000 square meter, GMP-compliant cleanroom, ensuring high standards for production.

The company's business is centered on providing medical devices for both cardiovascular and peripheral vascular interventions. Its revenue is generated through the sale of these devices to a wide range of clients. Domestically, Barty Medical's products are used in over 2,000 hospitals across 31 provinces. The company also has a significant international footprint, with its products being distributed in more than 20 countries, including South Korea, Turkey, Brazil, and several European nations.

Barty Medical's product portfolio is extensive, featuring devices with independent intellectual property rights. Key products include paclitaxel-eluting balloon catheters, drug-coated stents, introducer sheaths, angiography catheters, and guide catheters. The company also offers both SC/NC PTCA and PTA balloon catheters. This range of products addresses various needs within coronary and peripheral vascular procedures. In addition to its standard product lines, Barty Medical provides OEM services, leveraging its expertise in device design and manufacturing.

Since its founding, Barty Medical has focused on research and development, which has resulted in over 50 patents. The company has secured numerous certifications, including CE, ISO13485, and 11 NMPA registrations, underscoring its commitment to quality and regulatory compliance. Financially, the company has attracted investment through multiple funding rounds, including a Series C round in December 2023, raising a total of $32 million to support its growth and R&D initiatives.